XXXXXXXXX XXXXXXXXXX KOMISE (XX) 2020/528
xx xxx 14. xxxxx 2020,
kterým xx xxxxxxxxx xxxxxxxxxx x Xxxxxxxx, Číně, Xxxxx Koreji, Xxxxxxxxx xxxxxxx x Thajsku xx účelem xxxxxxxxx xxxxxxxxxxxxx xxxxx xxx xxxxxxxxx xxxxxxxxx xxxxxxxxxx xxxxx xxxxx vzteklině x psů, xxxxx x xxxxxx
(xxxxxxxx xxx xxxxxx X(2020) 2103)
(Xxxx s xxxxxxxx xxx XXX)
XXXXXXXX XXXXXX,
x xxxxxxx na Smlouvu x fungování Xxxxxxxx xxxx,
x ohledem xx xxxxxxxxxx Rady 2000/258/XX xx dne 20. xxxxxx 2000 o xxxxxx xxxxxxxxxx xxxxxxxxx xxxxxxxxxxx xx stanovení xxxxxxxx xxxxxxxxxx xxx xxxxxxxxxxx xxxxxxxxxxxxx testů xxx xxxxxxxxx xxxxxxxxx xxxxxxxxxx xxxxx xxxxx xxxxxxxxx&xxxx;(1), x xxxxxxx xx čl. 3 xxxx. 2 xxxxxxxxx xxxxxxxxxx,
xxxxxxxx k xxxxx xxxxxxx:
|
(1) |
Xxxxxxxxxx 2000/258/ES xxxxxx xxxxxxxxx Agence française xx xxxxxxxx sanitaire xxx xxxxxxxx (xxxx xxx „XXXXX“) ve xxxxxxxxxxxx Xxxxx jako xxxxxxxx institut xxxxxxxxx xx xxxxxxxxx xxxxxxxx xxxxxxxxxx xxx xxxxxxxxxxx xxxxxxxxxxxxx testů pro xxxxxxxxx účinnosti xxxxxxxxxx xxxxx xxxxx xxxxxxxxx. XXXXX xxxx nyní xxxxxxxxx xx Xxxxxx xxxxxxxxx xx sécurité xxxxxxxxx xx x’xxxxxxxxxxxx, xx l’environnement et xx xxxxxxx (xxxx xxx „XXXXX“) ve Xxxxxxx. |
|
(2) |
Xxxxxxxxxx 2000/258/XX mimo xxxx xxxxxxx, xx XXXXX xxxxxxx xxxxxxxxxx xx třetích xxxxxx, xxxxx xxxxxxxxxx xxxxxx x schválení xx xxxxxx xxxxxxxxx sérologických xxxxx xxx sledování xxxxxxxxx očkovacích xxxxx xxxxx xxxxxxxxx. |
|
(3) |
Xxxxxxxxx xxxxx x Brazílii xxxxxxxxx xxxxxx x schválení xxxxxxxxxx „Xxxxxx de Xxxxxxxxx em Raiva xx Xxxxxxxxxxx xx Xxxxxxxxx Xxxxxxx x Xxxxxxxxx xx Xxxxxxxxx xx Xxêxxxxx Biomédicas xx Xxxxxxxxxxxx xx Xãx Xxxxx“. ANSES xxx xxxx xxxxxxxxx xxxxxxxxxxx příznivou hodnotící xxxxxx xx dne 24. října 2019, xxxxxx xxxxxxxxxx Xxxxxx. |
|
(4) |
Xxxxxxxxx xxxxx Xxxx xxxxxxxxx xxxxxx x schválení xxxx laboratoří: „Sino Xxxx Xxxxx Xxxxxxxxxxx Xxxxxxxxxxxxxx Xx., Xxx (Xxxxxx)“ x „Xxxxxx Xxxxxxx Xxxxxxxxxx Xxxxxx xx xxx Xxxxxxxxx xx Xxxxxx Xxxxxx xx xxx Guangdong Xxxxxxx xx Agriculture Xxxxxxxx“. XXXXX pro xxxx laboratoře vypracovala xxxxxxxxx xxxxxxxxx xxxxxx xx xxx 24. xxxxx 2019, xxxxxx xxxxxxxxxx Xxxxxx. |
|
(5) |
Xxxxxxxxx orgán Xxxx xxxxxxxxx xxxxxx x xxxxxxxx xxxxxxxxx xxxx xxxxxxxxxx: „Xxxxxxxx Xxxxxxxxx Laboratory for Xxxxxx Xxxxxx (Diagnostic Xxxxxxxxxx xxx Xxxxxx xxx Xxxxxxxx Associated Xxxxxxxx)“ a „Xxxxxx xxx Rabies Xxxxxxxx Xxxxx of xxx Xxxxxxxxxx of Xxxxxxxxxxxx xx the Military Xxxxxxxxxx Research Xxxxxxxxx xx xxx Xxxxxxx xx Xxxxxxxx Xxxxxxx Xxxxxxxx“. XXXXX xxx xxxx xxxxxxxxxx vypracovala xxxxxxxxx hodnotící xxxxxx xx xxx 24. xxxxx 2019, xxxxxx xxxxxxxxxx Xxxxxx. |
|
(6) |
Xxxxxxxxx xxxxx Xxxxx Xxxxxx předložil xxxxxx x xxxxxxxxx xxxxxxxxxx „Xxxxxx xxx Xxxxxxxx xxxxxxxxxxxx XXX xxxxxxxxx laboratory xx Xxxxxx and Plant Xxxxxxxxxx Xxxxxx“. ANSES xxx tuto laboratoř xxxxxxxxxxx xxxxxxxxx xxxxxxxxx xxxxxx ze dne 24. xxxxx 2019, xxxxxx xxxxxxxxxx Xxxxxx. |
|
(7) |
Xxxxxxxxx xxxxx Xxxxxxx xxxxxxxxx xxxxxx x schválení xxxxxxxxxx „National Institute xx Xxxxxx Xxxxxx“. XXXXX pro tuto xxxxxxxxx vypracovala příznivou xxxxxxxxx xxxxxx xx xxx 24. října 2019, xxxxxx xxxxxxxxxx Xxxxxx. |
|
(8) |
Xxxxxxxxx orgán Spojených xxxxx xxxxxxxxx xxxxxx x xxxxxxxx xxxxxxxxx xxxxxxxxxx „Centers xxx Xxxxxxx Control and Xxxxxxxxxx of the Xxxxxx Xxxxxxxxxx“. ANSES xxx xxxx xxxxxxxxx xxxxxxxxxxx příznivou hodnotící xxxxxx xx xxx 24. xxxxx 2019, xxxxxx xxxxxxxxxx Xxxxxx. |
|
(9) |
Xxxx xxxxxxxxxx xx proto xxxx xxx schváleny xx xxxxxx xxxxxxxxx xxxxxxxxxxxxx xxxxx xxx xxxxxxxxx xxxxxxxxx očkovacích xxxxx xxxxx xxxxxxxxx x psů, xxxxx x fretek. |
|
(10) |
Opatření xxxxxxxxx xxxxx xxxxxxxxxxx jsou x souladu xx xxxxxxxxxxx Xxxxxxx xxxxxx xxx xxxxxxxx, xxxxxxx, xxxxxxxxx a xxxxxx, |
XXXXXXX XXXX XXXXXXXXXX:
Xxxxxx 1
X souladu x xx. 3 xxxx. 2 xxxxxxxxxx 2000/258/XX xx pro xxxxxxxxx sérologických xxxxx xx xxxxxx sledování xxxxxxxxx xxxxxxxxxx xxxxx xxxxx xxxxxxxxx x xxx, koček a xxxxxx xxxxxxxxx xxxx xxxxxxxxxx:
|
x) |
Xxxxxx xx Pesquisas xx Xxxxx Xxxxxxxxxxx xx Xxxxxxxxx Xxxxxxx x Xxxxxxxxx do Xxxxxxxxx xx Xxêxxxxx Biomédicas Xxxxxxxxxxxx xx Xãx Xxxxx Xx. Xxxx. Lineu Prestes, 1374, xxxx 225 05508-000 Xãx Paulo Xxxxxxxx |
|
b) |
Xxxx Tech Xxxxx Xxxxxxxxxxx Xxxxxxxxxxxxxx Xx., Xxx (Xxxxxxx) 29 Xxxxxxxx Xxxx Xxxx. Xxxxxxxxxx Medicine Base, Xxxxxx Xxxxxxxx, Xxxxxx Čína |
|
c) |
Animal Xxxxxxx Xxxxxxxxxx Center Xxxxxxxxx of Xxxxxx Xxxxxx, Xxxxxxxxx Xxxxxxx xx Xxxxxxxxxxx Xxxxxxxx 21 Xxxxxxxxxx Xxxxxx, Xxxxxx Xxxxxxxx Xxxxxxxxx, Guangdong Xxxx |
|
x) |
Xxxxxxxx Xxxxxxxxx Xxxxxxxxxx for Xxxxxx Xxxxxx (Diagnostic Xxxxxxxxxx xxx Rabies xxx Xxxxxxxx Associated Xxxxxxxx) Xxxxxxxxx Xxxxxxxxxx Xxxxxxxx Xxxxxxxxx, Chinese Academy xx Agricultural Xxxxxxxx 666 Xxxxxxx West Xxxx, Xxxxxxx Economy Xxxxxxxxxxx Xxxxxxxx, Changchun, Xxxxx, Xxxx |
|
x) |
Centre xxx Xxxxxx Xxxxxxxx Xxxxx, Xxxxxxxxxx xx Xxxxxxxxxxxx, Xxxxxxxx Veterinary Xxxxxxxx Xxxxxxxxx, Academy xx Xxxxxxxx Xxxxxxx Xxxxxxxx 666 Xxxxxxx Xxxx Xxxx, Xxxxxxx Xxxxxxx Xxxxxxxxxxx Xxxxxxxx Xxxxxxxxx, Xxxxx Xxxx |
|
f) |
Xxxxxx xxx Xxxxxxxx xxxxxxxxxxxx XXX reference laboratory xx xxx Animal xxx Xxxxx Xxxxxxxxxx Xxxxxx 177 Hyeoksin 8-xx, Xxxxxxxx-xx, Xxxxxxxxxxxxx-xx, 39660, Xxxxx Xxxxx |
|
x) |
Xxxxxxx for Disease Xxxxxxx xxx Prevention Rabies Xxxxxxxxxx 1600 Xxxxxxx Xxxx, XX, Xxxxxxx, GA 30333, Xxxxxxx xxxxx xxxxxxxx |
|
h) |
Xxx Xxxxxxxx Xxxxxxxxx xx Xxxxxx Xxxxxx 50/2 Xxxxxxxxxx, Xxxxxx, Xxxxxxxxx Xxxxxxx 10900 Xxxxxxx |
Xxxxxx 2
Xxxx xxxxxxxxxx xx určeno xxxxxxxx xxxxxx.
X Bruselu dne 14. xxxxx 2020.
Za Xxxxxx
Xxxxxx KYRIAKIDES
xxxxxx Komise
(1)&xxxx;&xxxx;Xx. xxxx. X 79, 30.3.2000, x. 40.